SCHEMBL11272339

SCHEMBL11272339

NCCCCC(N[C@@H](CCC(=O)O)C(=O)N1CCC[C@H]1C(=O)O)C(=O)O

nearest known ligand 0.71

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ ACE P12821 6/20 0.71
▸ REN P00797 1/20 0.54
▸ FOLH1 Q04609 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7324072 0.94 ACE (0.78) ACEREN
SCHEMBL682298 0.94 ACE (0.78) ACEREN
SCHEMBL7318593 0.93 ACE (0.77) ACE
SCHEMBL7330167 0.93 ACE (0.77) ACE
SCHEMBL7327307 0.88 ACE (0.70) ACEREN
SCHEMBL11268803 0.87 ACE (0.66) ACE
SCHEMBL30999001 0.86 ACE (0.71) ACE
Lisinopril Anhydrous SCHEMBL18938417 0.85 ACE (0.98) ACE
Lisinopril Anhydrous SCHEMBL21373192 0.85 ACE (0.98) ACE
SCHEMBL7325587 0.84 ACE (0.65) ACEREN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0049506-A1 N-carboxyalkyl dipeptides, a process for preparing and a pharmaceutical composition comprising the same MERCK & CO. INC. (US) 1982-04-14 — — EP disclosed
Send feedback